Entry Detail


General Information

Database ID: LDA0017613
Species: Homo sapiens
Confidence Score: 0.985791
Contents: >> ncRNA Information
>> ncRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference
Causality: Unknown
Clinical Significance: Unknown

 


ncRNA Information

Reference Genome Note: GRCh38 for human lncRNAs; GRCm39 for mouse lncRNAs; mRatBN7.2 for rat lncRNAs; hg19 for human circRNAs; mm9 for mouse circRNAs.

ncRNA Symbol:WFDC21P
Full Name:WAP four-disulfide core domain 21, pseudogene
Category:LncRNA
Species:Homo sapiens
Synonyms:LNCDC|linc-DC|lnc-DC
Chromosome:17
Strand:-
Coordinate:
Start Site(bp):60083566End Site(bp):60088467
External Links:
Ensembl ID:ENSG00000261040
Ensembl Transcript ID:N/A
Entrez Gene:645638.0
NONCODE ID:N/A
RefSeq Accession:N/A

 

ncRNA Association Statistics

Total Associated Disease Number:10   
More Information
Causal Disease Number:6
Network:
Top Causal Diseases:
Stomach Neoplasms  (Score: 0.731059)
Triple Negative Breast Neoplasms  (Score: 0.731059)
lung carcinoma  (Score: 0.731059)
Stomach Neoplasms  (Score: 0.731059)
Triple Negative Breast Neoplasms  (Score: 0.731059)
lung carcinoma  (Score: 0.731059)
More Information

 

 

Disease Information

 Disease OntologyMeSH
Disease ID:DOID:2377D009103
Disease Name:multiple sclerosisMultiple Sclerosis
Category:Disease OntologyMeSH
Type:Nervous System Diseases
Define:A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring.An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
Alias:Generalized multiple sclerosis//insular sclerosisMultiple Sclerosis//Sclerosis, Multiple//Sclerosis, Disseminated//Disseminated Sclerosis//MS (Multiple Sclerosis)//Multiple Sclerosis, Acute Fulminating

 

Disease Association Statistics

Total Associated ncRNA Number:36   
More Information
Causal ncRNA Number:0
Network:
Top Causal ncRNAs:
More Information

 

Evidence Support

Strong Evidence:qRT-PCR
Weak Evidence:

 

Reference

[1] PubMed ID:30514825
Disease Name:Multiple Sclerosis
Sample:blood
Dysfunction Pattern:Expression[highly expressed]
Validated Method:qRT-PCR
Description:MALAT1 and lnc-DC were significantly increased in MS patients (P=0.004 and P=0.006, respectively) in comparison with controls.
Causality:No
Causal Description:
Clinical-realted Application:

[2] PubMed ID:32951137
Disease Name:Multiple Sclerosis
Sample:HLA-DRB1*15:01-Negative Patients
Dysfunction Pattern:Expression(highly expressed)
Validated Method:qRT-PCR
Description:Our results have shown that lnc-DC expression level was significantly higher in total MS female patients compared with female controls (P = 0.0044).
Causality:No
Causal Description:
Clinical-realted Application: